Treating to Target for Patients With Hypertension
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01013857 |
Recruitment Status :
Completed
First Posted : November 16, 2009
Last Update Posted : March 21, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hypertension | Behavioral: Health coaching Behavioral: Health coaching plus home titration | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 240 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Treating to Target for Patients With Hypertension |
Study Start Date : | January 2009 |
Actual Primary Completion Date : | February 2010 |
Actual Study Completion Date : | December 2011 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Health coaching
Phone patients every week to discuss medication adherence
|
Behavioral: Health coaching
Calling patients every week to discuss medication adherence |
Experimental: Health coaching plus home-titration
Health coaches call patients every week to discuss medication adherence and to intensify medications if appropriate according to physician-created algorithm
|
Behavioral: Health coaching plus home titration
Calling patients every week and intensifying medications if appropriate based on physician-created algorithm |
- Systolic blood pressure [ Time Frame: 6 months ]
- Diastolic blood pressure [ Time Frame: 6 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 2 blood pressure readings above 145/90.
Exclusion Criteria:
- Cognitive impairment,
- Short life expectancy,
- Creatinine greater than 1.5,
- Inability to check blood pressures at home.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01013857
United States, California | |
San Francisco General Hospital | |
San Francisco, California, United States, 94110 |
Principal Investigator: | Thomas Bodenheimer, MD | University of California, San Francisco |
Responsible Party: | University of California, San Francisco |
ClinicalTrials.gov Identifier: | NCT01013857 |
Other Study ID Numbers: |
H40013-33128-02 |
First Posted: | November 16, 2009 Key Record Dates |
Last Update Posted: | March 21, 2022 |
Last Verified: | March 2022 |
Hypertension Vascular Diseases Cardiovascular Diseases |